首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Trends in endocrinology and metabolism

缩写:TRENDS ENDOCRIN MET

ISSN:1043-2760

e-ISSN:1879-3061

IF/分区:12.6/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引1568
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Christopher Lipina,Harinder S Hundal Christopher Lipina
Regulated in development and DNA damage response 1 (REDD1) has been functionally linked to the control of diverse cellular processes due, at least in part, to its ability to repress mammalian or mechanistic Target of Rapamycin (mTOR) Comple...
Linda Sasset,Yi Zhang,Teresa M Dunn et al. Linda Sasset et al.
Sphingolipids (SL) are both fundamental structural components of the eukaryotic membranes and signaling molecules that regulate a variety of biological functions. The highly-bioactive lipids, ceramide and sphingosine-1-phosphate, have emerg...
Karen L Chen,Zeynep Madak-Erdogan Karen L Chen
Recent advances have suggested that steroid hormones such as estrogens, and gut microbiota might synergize to influence obesity, diabetes, and cancer. We discuss recent knowledge of the interactions between estrogens and gut microbiota, and...
Rafael Moncada,Manuel F Landecho,Gema Frühbeck Rafael Moncada
A Joint Statement endorsed by 45 international organizations, clinicians, and researchers indicating when to recommend or consider metabolic surgery in type 2 diabetes mellitus (T2DM) treatment has been recently published. These new guideli...
M S Engelstoft,T W Schwartz M S Engelstoft
Gut hormones send information about incoming nutrients to the rest of the body and thereby control many aspects of metabolism. The secretion of ghrelin and glucagon-like protein (GLP)-1, two hormones with opposite secretory patterns and opp...
Luigi Gnudi,Richard J M Coward,David A Long Luigi Gnudi
Diabetes mellitus (DM) is the major cause of end-stage renal disease (ESRD) globally, and novel treatments are urgently needed. Current therapeutic approaches for diabetic nephropathy (DN) are focussing on blood pressure control with inhibi...
Timothy R Donahue,David W Dawson Timothy R Donahue
Pancreatic ductal adenocarcinoma (PDA) is a devastating malignancy with limited and modest clinical treatments. High-throughput technologies and accurate disease models now provide a comprehensive picture of the diverse molecular signaling ...